Upside is a financial technology entity that allows its users to earn cashbacks on current purchases so that they can save on their next purchase. The app uses an open-banking-marketing-platform that enables customers to automatically start saving by harvesting upside from their everyday spending and allows retailers to sell more inventory. Upside claims that 11.5 million people in the UK have less than £100 in savings. It aims to solve this problem and become a contender in the cashback segment. Since its incorporation in January 2020, Upside has raised £540,000+ from founders and SEIS Angel Investors. It has also signed-up 700+ consumers as private alpha testers to smoothen the app. The company will use the investment to onboard more retail partners, build out a self-serve retailer platform, build out Upside-as-a-Service Application Programming Interface (API) gateway, and prepare for Seed funding in Q1 of 2021.
days to go:
Expired
investment:
£351,047
YoungPlanet enables parents to put their children's unused things to use with new families and away from landfills for free via its app. The company cites PwC data estimating the UK’s sharing economy to be worth £9 billion by 2025. It aims to be a contender in this segment. The company argues further that 10-year-olds in the UK will own on average 238 toys at any one time and yet play with just 12. This leads to UK households wasting over 25 million tonnes a year, with one-fourth of this number ending up in landfills as per the Department for Environment, Food and Rural Affairs (DEFRA). YoungPlanet aims to change this. It has onboarded 36,000 users on its platform to date and featured in press publications such as BBC News, Vanessa Feltz, and LadBible. YoungPlanet will use the investment to scale nationally, begin generating first phase revenue via brand sponsorship of events, branded gamification, and Business-to-Business (B2B) subscriptions for semi-closed communities via its app.
days to go:
Expired
investment:
£547,103
eFOLDi a business that uses inventive engineering to unlock mobility in the less abled. It is a portable, lightweight and versatile mobility vehicle which can be folded to a suitcase size or used as a chair. The eFOLDi has an international patent, a registered trademark, passed various safety tests and won British invention of the year 2016
days to go:
Expired
investment:
£939,650
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.
days to go:
Expired
investment:
£144,265
Equipsme is a company that aims to democratise health insurance by making it affordable for businesses. The company offers flexible fixed-price packages to employees while giving them the option to upgrade their package to avail more features upon payment. Members can speak to a general physician round the clock, have physiotherapy sessions, avail regular health checks and, if necessary, be quickly referred to a consultant for diagnosis and treatment. Members can access these features through a simple-to-use application. Since February 2018, the company has secured an exclusive 5-year insurance capacity deal with AXA PPP Healthcare and grown its members by 130.5% Year-on-Year (YoY) (to May 2020) with a 95% broker renewal retention rate. The company will use the investment to enhance its user experience and scale its marketing as it announces its partnerships with organisations such as Starling Bank and Simply Business.
days to go:
Expired
investment:
£879,204
Hiro is an insurance technology company aiming to be a contender in the $6.9 trillion insurance industry. The company claims that conventional home insurance does nothing until the damage is already done. Hiro aims to change this scenario. It gives users access to smart technology to protect their property and rewards them accordingly by giving discounts on their insurance quote. The company has signed partnerships with 30+ leading device manufacturers towards this objective for example, Honeywell Home, Philips, and Lightwave, to name few. Hiro asserts that its platform, mobile apps, feature sets, and designs have been validated through an intensive insider's programme. Hiro is approved by the Financial Conduct Authority (FCA). The company has featured in publications like Forbes, the Guardian and the Evening Standard. Hiro will use the investment to develop Research and Development (R&D), furnish legal and compliance documents, and boost marketing and operations.
days to go:
Expired
investment:
£2,069,251
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
AndCo offers an open-source, cost-effective, sustainable solution to co-working by turning hotel lobbies and lavish eateries into co-working spaces all over London. The company has over 90 venues, over 1200 members and over 10 brand partnerships. It has been featured major publications including The Telegraph, Forbes, and The Metro. The funds raised will be used for marketing, development, hiring new teammates and working capital.
days to go:
Expired
investment:
£269,231
Equipsme is on a mission to democratise health insurance by making it affordable for businesses of all sizes. The company cites data arguing that there has been a 53% increase in National Health Service (NHS) treatment waiting lists since 2012 due to the low reach of health insurance by conventional insurance companies. It aims to change this scenario. Equipsme offers flexible fixed-price packages to companies wherein employees are allowed to upgrade and add family members to their plan as per their pleasure. Members can also speak to a General Physician (GP) 24/7, and, if necessary, be referred to a consultant for diagnosis and treatment through the company's proprietary app. The company was felicitated with the 'Best New Product' award by Cover Magazine Excellence Awards 2019. The company will use the investment to enhance its user experience, ensure its technology remains market-leading, and scale its marketing and customer service capability.
days to go:
Expired
investment:
£286,096
Genomes.io is a private and secure DNA data storage and sharing application. It aims at resolving the problem of DNA data breach and exploitation by allowing users to manage, store, sequence, and commercialise their genomic data. It aims to develop technology partnerships with population sequencing initiatives, rare disease organisations, as well as pharma and biotech companies. Genomes.io will allow its researchers to benefit from having better access to genomic data while protecting individual data owners. With the proceeds, the company will bring its B2C and B2B products to the market.
days to go:
Expired
investment:
£109,080
